JP Morgan Maintains Overweight on Nu Skin Enterprises (NUS)

JP Morgan is out with its report today on Nu Skin Enterprises NUS, maintaining Overweight. In a note to clients, JP Morgan writes, "We rate NUS Overweight. While Japan will continue to be an overhang, we think the stock is cheap at about 11.5x our downwardly revised 2012 estimate. Obviously, it is tough to determine what the net impact will be, but even if our numbers are too high, we think the valuation is compelling." Shares of NUS closed Tuesday at $30.06.